Today
Telix shares hit new high on upgraded revenue forecast
The biotech’s shares double in value this year due to strong sales in the United States for its prostate cancer imaging product.
- Michael Smith
Yesterday
Imricor Medical Systems in $35m raise
A presentation sent to potential backers said Imricor had spent 18 years and $US105 million ($155.7 million) on its technology.
- Sarah Thompson, Kanika Sood and Emma Rapaport
PE titans lob bids for Healius’ $700m Lumus Imaging; UBS offers staple
Many have taken a look at Healius’ Lumus Imaging, but it was TPG Capital and Affinity Private Equity that put pen to paper when UBS collected offers last week.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Ramsay’s French asset posts weaker earnings, launches debt refinancing
The healthcare provider says lower government subsidies and inflation are hurting the performance of its Ramsay Sante business.
- Michael Smith
This Month
Business with a smile: Genesis Capital ramps up fight for dental biz
With Genesis’ voting intentions out in the open, the coming weeks will see a flurry of activity in all camps.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Crescent Capital in by the skin of its teeth at Pacific Smiles
The private equity firm is facing an uphill battle to secure its ASX-listed target, with private equity rival Genesis Capital looming large on the register.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Heart Research Institute fights claim it ousted whistle-blower
The Heart Research Institute faces allegations it pushed out its former head of cardiovascular research because he raised concerns about underpayment of funds and conduct of board members.
- Max Mason
The research that favours swapping meat for cheese
If there’s one thing that can turn carnivores into plant-lovers, it’s those tasty products made from milk.
- Yasmin Tayag
- Opinion
- Healthcare
Vested interests at play in the chronic disease explosion
A search for good nutrition opened a Pandora’s box of snake oil salesmen and crackpot solutions. It also provided clues to the surging levels of chronic disease.
- Tony Boyd
- Sponsored
- NZTE
Kiwi impact on Aussie health and education
Over the past few years, New Zealand has increasingly become a hub for innovative companies making significant strides across industries and entire economic sectors.
Sponsored
by NZTE
- Opinion
- Investing
How to invest in the golden age of health disruption
Investing in healthcare in today’s market combines exposure to two key drivers – structural demand growth and disruptive innovation.
- Andrew McAuley
Hedge fund takes Barrenjoey to task over Chemist Warehouse deal
Faced with competition regulator concerns, Wickhams Hill reckons Chemist Warehouse is far more likely to pursue a traditional IPO than sell stores.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Forced smiles: Crescent Capital, Genesis get their fangs out
Pacific Smiles has been in a holding pattern since the dispute broke out.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Growth PE firm Whiteoak adds NDIS software provider
Whiteoak, a private equity firm founded by ex McKinsey & Co consultant Richard Whiteoak, has picked up a majority stake in Datanova.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Deutsche Bank backs $210m Bendigo Hospital public-private refinance
Street Talk understands the German bank has come in as the project’s long-term lender, refinancing an existing bank syndicate.
- Sarah Thompson, Kanika Sood and Emma Rapaport
I-MED snaps up US teleradiology player StatRad
Aussie imaging giant I-MED is hoping to recreate its fast-growing teleradiology business in the US with a major acquisition.
- Tess Bennett
$200m-a-year Opal HealthCare courts buyers; Morgan Stanley hired
While it remains to be seen how much of the business will be on offer, a big enough cheque will no doubt get everyone on board.
- Sarah Thompson, Kanika Sood and Emma Rapaport
June
AI beats the experts at detecting prostate cancer
When international AI teams competed with a pool of 62 radiologists in the first large-scale contest to diagnose prostate cancer, the machine won.
- Jill Margo
The Ozempic effect: How weight loss wonder drug gobbled up an economy
Pharmaceutical giant Novo Nordisk has grown so large in its native Denmark that it’s hard to find staff. Meanwhile, its philanthropic foundation is running out of local causes to support.
- Sanne Wass and Naomi Kresge
Radiopharm in $65m raise; Nasdaq-listed strategic pays 47pc premium
Diagnostics specialist Lantheus, capitalised at $8 billion on the Nasdaq, likes the look of Aussie company Radiopharm Theranostics.
- Sarah Thompson, Kanika Sood and Emma Rapaport
